AVALON Grand Plus is a non-surgical filler which contains highly-purified hyaluronic acid (24 mg\/ml) and lidocaine (0.3%) for anaesthetic effects.
\nIt is designed to be injected into the deep dermis for the correction of moderate to severe facial wrinkles and folds , cheeks, chin augmentation and shaping of the contours of the face and jawline.
\nThe viscous filler, AVALON\u2122 Grand Plus is an ideal solution for the correction of thick skin and deep wrinkles and it is also efficient in restoring volume with results lasting from 12 \u2013 18 months*.<\/p>\n
Cross-linked Hyaluronic Acid in AVALON\u2122 Fillers<\/strong><\/p>\n MCO\u2122 Tech. (Minimising Cross-linking-agent by Optimising reaction Technology) is a technology developed by Koru Pharma\u2019s R&D Institute. Indications<\/strong><\/p>\n Package<\/strong><\/p>\n 1 box \/ 1 syringe x 1 ml + 2 needles<\/p>\n *The duration of effect might vary depending on the individual physical characteristics of the patient, injection method and type of the procedure.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" Benefits<\/strong><\/p>\n
\nThe cross-linking agent serves to connect hyaluronic acid chains to form a net.
\nThrough optimisation of cross-linking reaction conditions in which a chemical reaction between the cross-linking agent and HA occurs, the use of the cross-linking agent is minimised, thereby maximising the efficiency of the cross-linking reaction.<\/p>\n\n
\n